WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006126030) MALARIA VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/126030    International Application No.:    PCT/GB2006/050127
Publication Date: 30.11.2006 International Filing Date: 26.05.2006
IPC:
C07K 14/445 (2006.01), C07K 19/00 (2006.01), C12N 15/30 (2006.01), C12N 15/62 (2006.01), A61K 39/002 (2006.01), G01N 33/569 (2006.01)
Applicants: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH [GB/GB]; Old College South Bridge, Edinburgh EH8 9YL (GB) (For All Designated States Except US).
MCBRIDE, Jana Strambachova [GB/GB]; (GB) (For US Only).
CAVANAGH, David Ronald [GB/GB]; (GB) (For US Only).
ARNOT, David Edward [GB/GB]; (GB) (For US Only)
Inventors: MCBRIDE, Jana Strambachova; (GB).
CAVANAGH, David Ronald; (GB).
ARNOT, David Edward; (GB)
Agent: IRVINE, Jonquil, Claire; Marks & Clerk, 4220 Nash Court, Oxford Business Park South, Oxfordshire OX4 2RU (GB)
Priority Data:
0510763.6 27.05.2005 GB
Title (EN) MALARIA VACCINES
(FR) VACCINS CONTRE LA MALARIA
Abstract: front page image
(EN)The present invention relates to a synthetic antigenic sequence which represents a combination of epitope-containing sequences from the highly polymorphic block 2 repeat region of Kl -type Plasmodium falciparum merozite surface antigen (MSPl) and fusion proteins containing that sequence. Such fusion proteins may also include a synthetic antigenic sequence similarly derived from MAD20 type block 2 repeat regions in MSPl.
(FR)L'invention concerne une séquence antigène synthétique représentant la combinaison de séquences contenant un épitope à partir de la zone de répétition du bloc 2 fortement polymorphe de l'antigène de surface du mérozoïte de Plasmodium falciparum (MSP1) et de protéines de fusion contenant cette séquence. Ces protéines de fusion peuvent également contenir une séquence antigène synthétique également dérivée des zones de répétition de bloc 2 du type MAD20 dans MSPl.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)